Windlas Biotech Limited Share Price Bombay S.E.

Equities

WINDLAS

INE0H5O01029

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:50 03/05/2024 BST 5-day change 1st Jan Change
548.4 INR -0.69% Intraday chart for Windlas Biotech Limited +0.40% +28.09%

Financials

Sales 2022 4.66B 55.85M 4.45B Sales 2023 5.13B 61.5M 4.9B Capitalization 4.71B 56.51M 4.5B
Net income 2022 381M 4.57M 364M Net income 2023 426M 5.11M 407M EV / Sales 2022 0.62 x
Net cash position 2022 1.69B 20.3M 1.62B Net cash position 2023 1.27B 15.22M 1.21B EV / Sales 2023 0.67 x
P/E ratio 2022
11.3 x
P/E ratio 2023
11.4 x
Employees 1,049
Yield 2022
1.67%
Yield 2023
1.78%
Free-Float 37.18%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.69%
1 week+0.40%
Current month-0.63%
1 month-0.63%
3 months+17.00%
6 months+50.87%
Current year+28.09%
More quotes
1 week
536.25
Extreme 536.25
568.65
1 month
505.00
Extreme 505
578.00
Current year
452.65
Extreme 452.65
590.00
1 year
256.00
Extreme 256
590.00
3 years
203.15
Extreme 203.15
590.00
5 years
203.15
Extreme 203.15
590.00
10 years
203.15
Extreme 203.15
590.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15/10/15
Founder 73 31/12/00
Compliance Officer - 17/03/21
Members of the board TitleAgeSince
Chairman 57 05/05/21
Director/Board Member 47 03/05/21
Founder 73 31/12/00
More insiders
Date Price Change Volume
03/05/24 548.4 -0.69% 4,884
02/05/24 552.2 +0.05% 3,997
30/04/24 551.9 +0.52% 10,880
29/04/24 549 +0.52% 3,509
26/04/24 546.2 -0.67% 3,529

Delayed Quote Bombay S.E., May 03, 2024 at 11:00 am

More quotes
Windlas Biotech Limited is an India-based company that is primarily engaged in the manufacturing and trading of pharmaceutical products. The Company provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. It has capabilities for both solid and liquid pharmaceutical dosage forms. The Company markets its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. It also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.
Calendar
More about the company